Michael Exton's Insider Trades & SAST Disclosures

Michael Exton's most recent trade in Lexicon Pharmaceuticals Inc was a trade of 503,263 Common Stock done . Disclosure was reported to the exchange on Feb. 28, 2026.

Share

Note

This is a custom search result for pattern Michael Exton.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Lexicon Pharma Inc High Gain High Volume	Michael Exton	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	503,263	503,263 (0%)	0%		-	Common Stock
Lexicon Pharma Inc High Gain High Volume	Michael Exton	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	28 Feb 2026	503,263	1,006,527	-		-	Restricted Stock Units
Lexicon Pharma Inc High Gain High Volume	Michael Exton	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share.	28 Feb 2026	204,831	298,432 (0%)	0%	1.5	301,102	Common Stock
Lexicon Pharma Inc High Gain High Volume	Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	1,293,670	1,293,670	-		-	Stock Option (Right to Buy)
Lexicon Pharma Inc High Gain High Volume	Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2026	862,440	862,440	-		-	Restricted Stock Units
Lexicon Pharma Inc High Gain High Volume	Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	2,264,690	2,264,690	-		-	Stock Option (Right to Buy)
Lexicon Pharma Inc High Gain High Volume	Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2025	1,509,790	1,509,790	-		-	Restricted Stock Units
Lexicon Pharma Inc High Gain High Volume	Michael Exton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2024	1,675,000	1,675,000	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades